MEDICI TECH LTD
Medici Tech Ltd is a technology company focused on advancing precision medicine through artificial intelligence.
Profile
Medici Tech uses AI to analyze healthcare data and provide personalized treatment recommendations for patients.
Medici Tech Ltd is a technology company focused on advancing precision medicine through artificial intelligence. Founded in the early 2020s, the company has built one of the world’s largest libraries of multimodal healthcare data, which it leverages to provide AI-enabled solutions for personalized patient care. Medici Tech operates in two primary business segments: diagnostics and data applications.
In 2025, the company reported preliminary revenue of approximately $1.27 billion, an 83% year-over-year increase, driven by strong growth in both segments. Diagnostics revenue grew 111% to $955 million, while data and applications revenue rose 31% to $316 million. The company’s oncology and hereditary diagnostics volumes saw significant growth, with oncology volume up 26% and hereditary volume up 29%.
Medici Tech’s AI-driven platform is designed to improve treatment outcomes by learning from historical patient data, positioning it as a key player in the precision medicine space. Recent momentum has been fueled by partnerships with major healthcare providers and pharmaceutical companies, though the company faces scrutiny over data privacy and the scalability of its AI models.
Who buys this
- Healthcare providers and hospitals
- Pharmaceutical and biotech companies
- Research institutions and academic medical centers
- Genetic testing laboratories
- Health insurers and payers
Strengths and what to watch
Strengths
- Strong revenue growth, with 83% year-over-year increase in 2025
- Large and growing library of multimodal healthcare data
- Dual revenue streams from diagnostics and data applications
Watch for
- Dependence on a few key partnerships for revenue growth
- Regulatory scrutiny around data privacy and AI in healthcare
- High operational costs associated with scaling AI and diagnostics infrastructure
Key Information
- Founded
- 2020
Frequently Asked Questions
What does Medici Tech do in healthcare?
Medici Tech uses artificial intelligence to analyze healthcare data and provide personalized treatment recommendations. Their AI platform learns from historical patient data to improve outcomes, focusing on precision medicine. The company operates in diagnostics and data applications, serving providers, pharma companies, and research institutions.
How fast is Medici Tech growing?
Medici Tech reported 83% year-over-year revenue growth in 2025, reaching $1.27 billion. Diagnostics revenue grew 111% to $955 million, while data applications rose 31% to $316 million. Oncology and hereditary diagnostics volumes increased by 26% and 29% respectively, showing strong momentum across business segments.
Who uses Medici Tech's AI platform?
Medici Tech serves healthcare providers, hospitals, pharmaceutical companies, and research institutions. Their customers also include genetic testing labs and health insurers. The platform helps these organizations leverage AI for personalized patient care, drug development, and clinical research through data-driven insights.
What are the risks of Medici Tech's business model?
Key risks include dependence on major partnerships for growth, regulatory scrutiny around healthcare data privacy, and high costs of scaling AI infrastructure. The company faces challenges balancing rapid expansion with maintaining compliance in the tightly regulated healthcare industry.
How does Medici Tech's AI improve diagnostics?
The platform analyzes multimodal healthcare data to identify patterns and recommend personalized treatments. By learning from historical patient outcomes, the AI enhances diagnostic accuracy in areas like oncology and hereditary conditions, where volumes grew 26% and 29% respectively in 2025.
What makes Medici Tech different in AI healthcare?
Medici Tech combines one of the world's largest healthcare data libraries with specialized AI models for precision medicine. Their dual focus on diagnostics and data applications creates complementary revenue streams, while partnerships with major providers accelerate real-world implementation of their technology.
Sources
- www.sec.gov — 2025 preliminary financial results and business segments